PF-04937319

DRUG3 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2HealthyNIDDMType 2 Diabetes Mellitus

Phase 1

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

CompletedNCT01044537

PfizerType 2 Diabetes Mellitus

Start: 2010-02-28End: 2010-05-31Updated: 2017-03-10

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

CompletedNCT01272804

PfizerDiabetes Mellitus, Type 2, NIDDM

Start: 2011-02-28End: 2011-07-31Updated: 2017-02-01

A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects

CompletedNCT01513928

Start: 2012-01-31End: 2012-02-29Updated: 2012-03-12